CRP and rheumatoid arthritis: In patients with RA who receive biologics and cDMARDs, the leading predictive features of the performance of DAS28, according to SHAP values, are VAS (0.438), Physician's Global Assessment (0.234), CRP (0.206), TOC (0.18), and morning stiffness (0.113).